
	Ms. Rubinstein joined PaxVax in 2014 as Executive Vice President and Chief Financial Officer. She has more than 25 years of operational, financial, and capital markets experience in life science, software, and investment banking. Previously, she served as Senior Vice President and Chief Financial Officer of Ingenuity Systems, which was acquired by QIAGEN in 2013, and Vice President and Chief Financial Officer of Solexa, which was acquired by Illumina in 2007. In these roles, she oversaw finance operations, conducted financing and M&amp;A transactions, and contributed to corporate strategy. As an investment banker, she completed over 30 transactions on behalf of Lehman Brothers and Merrill Lynch, among others, raising over five billion in capital for companies ranging from emerging start-ups to Fortune 500 companies. Ms. Rubinstein earned her B.A. and M.A. degrees in economics from the University of California, Los Angeles.
